Postdoctoral Fellow at University of North Carolina Chapel Hill

The Division of Pharmacoengineering and Molecular Pharmaceutices (DPMP) seeks to create new methods of targeted delivery to optimize therapeutic efficacy of drugs and vaccines. This is accomplished by the integration of drug-delivery science, nanotechnology, and pharmacoengineering, an emerging discipline that integrates engineering methods with pharmaceutical sciences. The division works closely with other divisions within the UNC Eshelman School of Pharmacy, as well as other divisions across campus, including numerous researchers from the Lineberger Comprehensive Cancer Center. DPMP researchers have generated more than $8.5M in annual support from the NIH and NSF. This includes the NIH-funded Center for Nanotechnology in Drug Delivery that brings together scientists to create nano-scale pharmaceutical innovations for therapeutic and diagnostic purposes. Building on a new partnership partnership between the J. Craig Venter Institute and The Hingtgen Lab, we seek to fill a post-doctoral position. The work will focus on an exciting new project aimed at creating the next-generation cell therapy by working at the interface of synthetic biology and cell therapy. Foundations of this work include:

1. Sci Transl Med. 2017 Feb 1;9(375). pii: eaah6510 2. Nat Commun. 2016 Feb 2;7:10593